Terms: = Kaposi Sarcoma AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
4 results:
1. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma.
Ishikawa C; Mori N
Invest New Drugs; 2021 Feb; 39(1):111-121. PubMed ID: 32885355
[TBL] [Abstract] [Full Text] [Related]
2. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
[TBL] [Abstract] [Full Text] [Related]
3. Immunomodulatory drugs target IKZF1-IRF4-myc axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract] [Full Text] [Related]
4. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm.
Karcher DS; Alkan S
Hum Pathol; 1997 Jul; 28(7):801-8. PubMed ID: 9224748
[TBL] [Abstract] [Full Text] [Related]
